AdvertisementApart from China's Sinovac Biotech and Russia's Gamaleya Research Institute, the Philippines is also evaluating Johnson & Johnson's Janssen unit's application to conduct Phase 3 trials of its COVID-19 vaccine.The Philippines' health ministry on Monday recorded 1,607 new coronavirus infections and 62 more deaths.
In a bulletin, the ministry said total confirmed cases had increased to 371,630, while deaths had reached 7,039.Travellers to other countries are required to show confirmed round-trip tickets, travel and health insurance, a declaration acknowledging the risks of travel and trip delays, and a medical test within 24 hours of departure that clears them of COVID-19.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Qatar signs deal to buy Moderna COVID-19 vaccineQatar has signed an agreement with drugmaker Moderna Inc to buy its potential COVID-19 vaccine as soon as it is approved and released for global ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
France's new COVID-19 cases could be 100,000 per day: Government medical advisorPARIS: France may be experiencing 100,000 new COVID-19 cases per day - twice the latest official figure - Professor Jean-François Delfraissy, who ... Omg. So powerful second wave ☹️
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
WHO chief warns against COVID-19 'vaccine nationalism'The head of the World Health Organization (WHO) on Sunday (Oct 25) called for global solidarity in the rollout of any future coronavirus vaccine, ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Oxford Covid-19 vaccine trials produce robust immune response in elderly: MediaLONDON (REUTERS) - The Covid-19 vaccine being developed by the University of Oxford and AstraZeneca Plc produces a robust immune response in elderly people, the group at highest risk, the Financial Times said on Monday (Oct 26), citing early results.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »
Oxford COVID-19 vaccine trials produce robust immune response in elderly: ReportEarly results from tests for a coronavirus vaccine being developed by the University of Oxford, in collaboration with AstraZeneca Plc, show it ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
UK considers reducing quarantine period for COVID-19 contactsBritain's government is looking at how long those exposed to COVID-19 need to quarantine, Northern Ireland minister Brandon Lewis told Sky News on ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »